Concepedia

Publication | Closed Access

Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia

DOI

562

Citations

39

References

2006

Year

Deborah A. Thomas, Stefan Faderl, Susan O’Brien, Carlos E. Bueso‐Ramos, Jörge E. Cortes, Guillermo Garcia‐Manero, Francis J. Giles, Srđan Verstovšek, William G. Wierda, Sherry Pierce,
Cancer

Abstract

The addition of rituximab to hyper-CVAD may improve outcome in adult BL or B-ALL, particularly in elderly patients.

References

YearCitations

Page 1